Status:
UNKNOWN
Urinary and Sexual Dysfunctions Evaluation After Rectal Resection
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Advances in the treatment of rectal cancer over the past two decades have improved survival and significantly reduced surgery-related morbidity. As a result, post-treatment quality of life (QoL) issue...
Eligibility Criteria
Inclusion
- All patients with a histopathological proven diagnosis of rectal carcinoma undergoing curative surgical resection
Exclusion
- Patients aged \< 18 years
- Inability to give informed consent
- Emergent surgeries
- Previous prostatic and/or colorectal surgery for benign or malignant diseases
- Preoperative sexual disorders (Female Sexual Function Index, FSFI ≤ 26.55 ; International Index Erectile Function , IIEF \< 16)
- International Consultation on Incontinence Questionnaire \> 5
- Clinically evident Benign Prostatic Hypertrophy (BPH) (International Prostatic Symptoms Score, IPSS \> 20)
- Preoperative diagnosis of fecal and/or urinary incontinence.
Key Trial Info
Start Date :
February 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 20 2024
Estimated Enrollment :
1172 Patients enrolled
Trial Details
Trial ID
NCT04404673
Start Date
February 21 2020
End Date
February 20 2024
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma
Rome, Lazio, Italy, 00168